---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-018607"
form_type: "8-K"
ticker: "AYTU"
cik: "0001385818"
company_name: "AYTU BIOPHARMA, INC"
filed_at: "2022-12-13T23:59:59+00:00"
generated_at: "2026-06-21T05:15:55.632474+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aytu BioPharma dismisses Plante & Moran, appoints Grant Thornton as auditor

## Summary
- Dismissed Plante & Moran on Dec 12, 2022; reports had no adverse opinions but FY2022 included going concern explanatory paragraph.
- Appointed Grant Thornton LLP as independent auditor for fiscal year 2023.
- No disagreements on accounting principles; material weakness in impairment analysis previously reported and remediated.
- Grant Thornton had not been consulted on any accounting matters prior to engagement.

## SEC filing metadata
- accession: 0001558370-22-018607
- form_type: 8-K
- ticker: AYTU
- cik: 0001385818
- company_name: AYTU BIOPHARMA, INC
- filed_at: 2022-12-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1385818/000155837022018607/0001558370-22-018607-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1385818/000155837022018607/aytu-20221212x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-018607
- JSON: https://secwatch.observer/filing/0001558370-22-018607.json
- Plain text: https://secwatch.observer/filing/0001558370-22-018607.txt

## Key facts
- Auditor Changes
  AYTU BIOPHARMA, INC dismissed Plante & Moran PLLC as its auditor.
  - Action: dismissal
  - Auditor: Plante & Moran PLLC
  - Successor: Grant Thornton LLP
  source text: On December 12, 2022, the Audit Committee of the Board of Directors of Aytu BioPharma, Inc. (the “Company”) dismissed Plante & Moran PLLC (“Plante Moran”), as the Company’s independent registered public accounting firm.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1385818/000155837022018607/0001558370-22-018607-index.htm
- Auditor Changes
  AYTU BIOPHARMA, INC engaged Grant Thornton LLP as its auditor.
  - Action: engagement
  - Auditor: Grant Thornton LLP
  source text: On December 12, 2022, the Audit Committee appointed Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1385818/000155837022018607/0001558370-22-018607-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.